Cardiovascular risks, bleeding risks, and clinical events from 3 phase III trials of pirfenidone in patients with #IPF: https://t.co/3to7Nxnoes
41,094 followers
186 followers
RT @atscommunity: Cardiovascular risks, bleeding risks, and clinical events from 3 phase III trials of pirfenidone in patients with #IPF: h…
41,094 followers
Cardiovascular risks, bleeding risks, and clinical events from 3 phase III trials of pirfenidone in patients with #IPF: https://t.co/3to7Nxnoes
944 followers
RT @AdvancesTherapy: Just published: "Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of #Pirfenidone in…
1,220 followers
Just published: "Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of #Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis": https://t.co/aJASYInE6b #IPF #openaccess https://t.co/AH4fs3y1Z9